Prognostic significance of preoperative serum tumor markers in hepatoid adenocarcinoma of stomach (HAS)

Abstract

Applying preoperative serum AFP level to predict the HAS patients' prognosis is feasible and preoperative serum high-AFP is an independent risk factor for OS and RFS of HAS patients. Preoperative serum CA19-9 could be an alternative choice when AFP was absent.